With the 2026 NFL schedule now officially released, sportsbooks wasted no time posting opening lines for Week 1. Headlined by a Wednesday night Super Bowl rematch between the Seahawks and Patriots, as ...

In a battle of two Heisman winners, Baker Mayfield and the Tampa Bay Buccaneers will head to Paycor Stadium to face Joe Burrow and the Cincinnati Bengals as part of Sunday’s afternoon schedule.

When the NFL releases the schedule for the upcoming regular season, it's a small form of torture. Sure, we get to see the roadmap for the upcoming year and all the great games we have in store for us, ...

NEW YORK, May 8 (Reuters) - The rallying U.S. stock market will take its cues next week from inflation and consumer spending data, developments in the war in Iran, and a high-stakes meeting between ...

Sometimes, it's best to go by the numbers. Each week, Law.com is telling critical legal stories through data visualizations. In this week's roundup: How Florida's AI rules might be ushering in a new ...

Amazon One Medical has launched a GLP-1 management program that integrates primary care, pharmacy services and virtual care options to simplify the patient experience. The program aims to address ...

Amazon.com AMZN-1.23%decrease; red down pointing triangle is launching a program that provides access to GLP-1 treatments through its One Medical primary care arm. The company said Tuesday the new ...

Representatives of the crypto and banking industries are meeting with legislative staffers on Thursday and Friday to review revised compromise language on stablecoin yield provisions in the market ...

Provisional purchasing managers’ surveys for March in the U.S. and Europe in the week will provide a key gauge of how the ongoing war in the Middle East has impacted sentiment and business activity.

Structure Therapeutics reported highly positive Phase 2 ACCESS II data for aleniglipron, achieving ~16% placebo-adjusted weight loss with strong statistical significance and no plateau. Aleniglipron’s ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Structure Therapeutics said Monday that its ...